Mirae Asset Global ETFs Holdings’s Tango Therapeutics TNGX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Buy	73,897 +14,360	+24%	+$355K	﹤0.01%	1166
2026 Q1	$1.23M	Sell	59,537 -3,097	-5%	-$43.1K	﹤0.01%	1419
2025 Q4	$552K	Buy	62,634 +22,236	+55%	+$192K	﹤0.01%	1839
2025 Q3	$340K	Sell	40,398 -1,600	-4%	-$10.8K	﹤0.01%	2047
2025 Q2	$215K	Buy	41,998 +13,360	+47%	+$33K	﹤0.01%	2247
2025 Q1	$39.2K	Buy	28,638 +1,227	+4%	+$3.01K	﹤0.01%	2887
2024 Q4	$84.7K	Sell	27,411 -2,886	-10%	-$13.4K	﹤0.01%	2771
2024 Q3	$232K	Buy	30,297 +4,775	+19%	+$45.6K	﹤0.01%	2303
2024 Q2	$219K	Buy	+25,522	New	+$197K	﹤0.01%	2203

Other funds holding TNGX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TNGX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Tango Therapeutics (TNGX) stake by 24% in Q2 2026, buying an estimated $355K and bringing the position to 73,897 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Mirae Asset Global ETFs Holdings first reported a position in TNGX in Q2 2024 and has held it in 9 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 73,897 shares of Tango Therapeutics worth $2.32M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 14,360 Tango Therapeutics shares in Q2 2026, an estimated $355K.
Tango Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1166 holding.
Mirae Asset Global ETFs Holdings first reported a position in Tango Therapeutics in Q2 2024 and has held it in 9 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.